\-\ Texto\\:\\ \ \(0\)\
\-\ there\\ is\\ an\\ increase\\ in\\ size\\ of\\ the\\ homogeneously\\ enhancing\\ mass\\ that\\ extends\\ from\\ the\\ posterior\\ left\\ orbit\\ along\\ the\\ left\\ optic\\ nerve\\ to\\ the\\ anterior\\ clinoid\\ process\\.\\ it\\ contacts\\ the\\ left\\ superior\\ oblique\\ and\\ left\\ lateral\\ rectus\\ muscles\\ as\\ well\\ as\\ the\\ supraclinoid\\ portion\\ of\\ the\\ left\\ internal\\ carotid\\ arteries\\.\\ invasion\\ of\\ these\\ structures\\ cannot\\ be\\ ruled\\ out\\.\\ the\\ intracranial\\ portion\\ of\\ the\\ tumor\\ measures\\ 1\\.4\\ x\\ 1\\.6\\ x\\ 1\\.1cm\\ as\\ compared\\ to\\ 1\\ x\\ 1\\.2\\ x\\ 1cm\\ on\\ the\\ latest\\ comparison\\ study\\ in\\ 2003\\.\\ the\\ intraorbital\\ portion\\ of\\ the\\ tumor\\ measures\\ 2\\.4\\ x\\ 1\\.5\\ x\\ 1\\.1cm\\ as\\ compared\\ to\\ approximately\\ 1\\ x\\ 1\\ x\\ 1cm\\ in\\ 2003\\.\ \(0\)\
\-\ orbital\\ optic\\ nerve\\ meningioma\ \(0\)\
\-\ glioma\ \(339\)\
\-\ neuroma\ \(42\)\
\-\ patient\\ is\\ status\\ post\\ left\\ frontal\\ craniotomy\\ in\\ 2002\\ for\\ resection\\ of\\ an\\ intracranial\\ meningioma\\.\\ she\\ presented\\ with\\ a\\ seizure\\ and\\ left\\ sided\\ vision\\ loss\\.\\ a\\ follow\\ up\\ mri\\ was\\ obtained\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ x\\:\\ 0\\.1474021613253583\ \(0\)\
\-\ 1\\.1cm\\:\\ 0\\.1008745900039005\ \(0\)\
\-\ 2003\\.\\:\\ 0\\.08073805352093123\ \(0\)\
\-\ 1cm\\:\\ 0\\.06952955375817017\ \(0\)\
\-\ portion\\:\\ 0\\.06069032641880562\ \(0\)\
\-\ optic\\:\\ 0\\.05170857541967093\ \(0\)\
\-\ latest\\:\\ 0\\.048557020018605276\ \(0\)\
\-\ measures\\:\\ 0\\.04779690359152901\ \(0\)\
\-\ compared\\:\\ 0\\.047281325394780034\ \(0\)\
\-\ intracranial\\:\\ 0\\.047209303750192194\ \(0\)\
\-\ clinoid\\:\\ 0\\.047098565434852274\ \(0\)\
\-\ supraclinoid\\:\\ 0\\.04590692127280028\ \(0\)\
\-\ intraorbital\\:\\ 0\\.04402664628945531\ \(0\)\
\-\ left\\:\\ 0\\.04374337833274773\ \(0\)\
\-\ meningioma\\:\\ 0\\.04295541616281144\ \(0\)\
\-\ nerve\\:\\ 0\\.04024766178414779\ \(0\)\
\-\ 1\\:\\ 0\\.039869144469798175\ \(0\)\
\-\ neuroma\\:\\ 0\\.03949627256030534\ \(0\)\
\-\ contacts\\:\\ 0\\.03771892801466062\ \(0\)\
\-\ 1\\.4\\:\\ 0\\.035609297999869435\ \(0\)\
\-\ 1\\.2\\:\\ 0\\.03517340666327681\ \(0\)\
\-\ 1\\.6\\:\\ 0\\.03496589883115537\ \(0\)\
\-\ 2\\.4\\:\\ 0\\.03476477687908509\ \(0\)\
\-\ as\\:\\ 0\\.03379287597108831\ \(0\)\
\-\ craniotomy\\:\\ 0\\.03350744424740237\ \(0\)\
\-\ homogeneously\\:\\ 0\\.03259396749985231\ \(0\)\
\-\ rectus\\:\\ 0\\.03231580008535038\ \(0\)\
\-\ ruled\\:\\ 0\\.031078924270719472\ \(0\)\
\-\ 2002\\:\\ 0\\.030538455539705658\ \(0\)\
\-\ comparison\\:\\ 0\\.029059284781042333\ \(0\)\
\-\ orbit\\:\\ 0\\.02813502560424607\ \(0\)\
\-\ 1\\.5\\:\\ 0\\.027923030337885586\ \(0\)\
\-\ invasion\\:\\ 0\\.026895673582837138\ \(0\)\
\-\ orbital\\:\\ 0\\.026492447641625765\ \(0\)\
\-\ tumor\\:\\ 0\\.026042252308638054\ \(0\)\
\-\ oblique\\:\\ 0\\.025956413970639917\ \(0\)\
\-\ vision\\:\\ 0\\.025803816820332785\ \(0\)\
\-\ muscles\\:\\ 0\\.025508912014578083\ \(0\)\
\-\ glioma\\:\\ 0\\.02518087446867053\ \(0\)\
\-\ carotid\\:\\ 0\\.025045175178157922\ \(0\)\
\-\ seizure\\:\\ 0\\.024696508637600454\ \(0\)\
\-\ extends\\:\\ 0\\.024206082585685983\ \(0\)\
\-\ increase\\:\\ 0\\.02342751507916282\ \(0\)\
\-\ arteries\\:\\ 0\\.02312028604402602\ \(0\)\
\-\ process\\:\\ 0\\.02150369597931186\ \(0\)\
\-\ structures\\:\\ 0\\.02150369597931186\ \(0\)\
\-\ sided\\:\\ 0\\.020650500739520558\ \(0\)\
\-\ status\\:\\ 0\\.019936779877004273\ \(0\)\
\-\ obtained\\:\\ 0\\.019855333991789816\ \(0\)\
\-\ size\\:\\ 0\\.018724678897900467\ \(0\)\
\-\ internal\\:\\ 0\\.018724678897900467\ \(0\)\
\-\ along\\:\\ 0\\.018457868476199454\ \(0\)\
\-\ out\\:\\ 0\\.018457868476199454\ \(0\)\
\-\ study\\:\\ 0\\.018376675535032413\ \(0\)\
\-\ superior\\:\\ 0\\.0178349261245372\ \(0\)\
\-\ follow\\:\\ 0\\.017746401777427673\ \(0\)\
\-\ post\\:\\ 0\\.01758715707890388\ \(0\)\
\-\ frontal\\:\\ 0\\.017544391728649394\ \(0\)\
\-\ enhancing\\:\\ 0\\.017516036162645486\ \(0\)\
\-\ resection\\:\\ 0\\.01741774938248509\ \(0\)\
\-\ approximately\\:\\ 0\\.017279855075526686\ \(0\)\
\-\ loss\\:\\ 0\\.01621218413378065\ \(0\)\
\-\ she\\:\\ 0\\.01567834079381812\ \(0\)\
\-\ an\\:\\ 0\\.015446599533133723\ \(0\)\
\-\ presented\\:\\ 0\\.015224559706028819\ \(0\)\
\-\ up\\:\\ 0\\.01501860883041976\ \(0\)\
\-\ these\\:\\ 0\\.014534932627175427\ \(0\)\
\-\ anterior\\:\\ 0\\.014384266821978676\ \(0\)\
\-\ posterior\\:\\ 0\\.01287345456668267\ \(0\)\
\-\ mri\\:\\ 0\\.012831868332775293\ \(0\)\
\-\ can\\:\\ 0\\.012668119950778232\ \(0\)\
\-\ well\\:\\ 0\\.012634516032474844\ \(0\)\
\-\ it\\:\\ 0\\.01255456460479096\ \(0\)\
\-\ lateral\\:\\ 0\\.012069725788395755\ \(0\)\
\-\ in\\:\\ 0\\.01101692104941843\ \(0\)\
\-\ the\\:\\ 0\\.010843081153225553\ \(0\)\
\-\ that\\:\\ 0\\.00964693286639754\ \(0\)\
\-\ be\\:\\ 0\\.008612789041463589\ \(0\)\
\-\ to\\:\\ 0\\.00837388447927424\ \(0\)\
\-\ there\\:\\ 0\\.00831186638212411\ \(0\)\
\-\ from\\:\\ 0\\.008277357602315114\ \(0\)\
\-\ not\\:\\ 0\\.008070710272823108\ \(0\)\
\-\ mass\\:\\ 0\\.007767718999657285\ \(0\)\
\-\ is\\:\\ 0\\.007350206253395107\ \(0\)\
\-\ was\\:\\ 0\\.006459330210546973\ \(0\)\
\-\ patient\\:\\ 0\\.005598640071348941\ \(0\)\
\-\ a\\:\\ 0\\.005184311134883677\ \(0\)\
\-\ for\\:\\ 0\\.004765412736226896\ \(0\)\
\-\ on\\:\\ 0\\.0047313138063099875\ \(0\)\
\-\ of\\:\\ 0\\.004568776501881899\ \(0\)\
\-\ and\\:\\ 0\\.002353058898460372\ \(0\)\
\-\ \\.\\:\\ 0\\.0013921386704841675\ \(0\)\
\-\ with\\:\\ 0\\.0007647331770581029\ \(0\)\
